Skip to content

News

Interview with Scailyte Founder Prof. Dr. Manfred Claassen

In an interview with Investiere our founder and scientific advisor Prof. Dr. Manfred Claassen describes how our understanding of biology is advancing thanks to technological progress. Scailyte is on a mission to save millions of lives by developing single-cell precision diagnostics.
Read More

Postdoc (Ph.D.) opportunity in Molecular Biology

This postdoctoral Research position in the laboratory of Endometriosis and Gynecological Oncology is a funded collaboration between Inselspital and Scaïlyte AG
Read More

Scailyte: simplifying difficult diagnoses

Making a diagnosis can be a tricky endeavour. For instance, diagnosing skin T-cell lymphoma, a rare form of cancer for which early detection can greatly boost survival, takes on average six years, because the skin rashes associated with it are difficult to interpret.
Read More

Scailyte among The Spinoff Prize finalists

Scailyte is among the ten selected young science-based university spinoff companies that showcase their visions and strategies in the final rounds of a new award created by Nature Research and Merck.
Read More

Scailyte closes pre-series A financing round

Scailyte raises CHF 3.1 million in a pre-series A financing round led by Swisscom Ventures to further advance its biomarker discovery platform.
Read More
Making groundbreaking discoveries require collaborations and joint-ventures.